Elizabeth A Poplin, MD - Robert Wood Johnson Medical Group

Rutgers Cancer Institute of New Jersey, located in New Brunswick, NJ, is a comprehensive cancer center that offers a wide range of specialized programs and services for adult and pediatric patients. Their team of expert physicians and researchers are dedicated to providing cutting-edge treatments and conducting innovative research to improve cancer care and outcomes. With a multidisciplinary approach, Rutgers Cancer Institute of New Jersey offers programs in areas such as blood and marrow transplant, breast oncology, gastrointestinal oncology, head and neck oncology, leukemia and lymphoma, melanoma, neuro-oncology, pediatric hematology oncology, and more. They also provide patient support services, clinical trials, and precision medicine options to ensure personalized and effective cancer treatment for every patient.Generated from the website

Jocelyn A Lewis DO - Cancer Institute of New Jersey, located in New Brunswick, NJ, is a comprehensive cancer center offering a wide range of adult oncology programs, pediatric stem cell transplantation, and specialized care for various types of cancer including breast, lung, and skin cancer. The institute provides state-of-the-art treatments such as car T cell therapy, precision medicine, and radiation therapy, along with patient support services, clinical trials, and a survivorship program to ensure the best possible outcomes for cancer patients. Generated from the website

Robert S. Dipaola, MD, is affiliated with the Robert Wood Johnson Medical Group and offers specialized oncology services at the Jack Sheryl Morris Cancer Center in New Brunswick, NJ, set to begin in late spring 2025. The center is recognized as a Comprehensive Cancer Center, providing a wide array of adult and pediatric oncology programs, including advanced therapies and surgical services. With a focus on patient care, the institute emphasizes multidisciplinary approaches to treatment, encompassing various cancer types and support services. Their commitment to research and clinical trials aims to enhance cancer prevention, treatment, and survivorship outcomes for patients and their families. Generated from the website